The objective of this research was to determine the minimum inhibitory concentration of the essential oil of Eucalyptus globulus Labill leaves on the growth of Streptococcus pyogenes ATCC 19615.
Urbina Saldaña, Jersy Guadalupe +1 more
core
La bacteria Burkholderia glumae es considerada el principal agente causal del añublo bacterial que afecta la panícula del arroz (Oriza sativa L.), generando pérdidas en su producción y requiriéndo medidas de control más efectivas.
Padilla Sierra, Hilda Angélica
core
The control of microbial growth is an important factor in food preservation, for which chemicals are commonly used; however, these are being replaced by natural substances such as essential oils.
Mantilla German, Susana Fiorella +1 more
core
Zinc oxide nanoparticles represent an alternative to implement efficient measures to inhibit the growth of various microorganisms, especially bacteria like Klebsiella pneumoniae.
ARIAS LÓPEZ, Pamela María de Fátima +1 more
core
In vitro and Quantitative and Structure Activity Relationship (QSAR) evaluation of the antifungal activity of terpenoid constituents of essential oils against Alternaria alternata and Fusarium oxysporum [PDF]
Andrade-Ochoa S +3 more
europepmc +1 more source
Gene expression profiles of ERG11, MDR1 and AFR1 in Cryptococcus neoformans var.grubbi from HIV patients [PDF]
Torres I +5 more
europepmc +1 more source
[Pharmacokinetic monitoring of linezolid: <i>Enterococcus faecium</i> infection in a kidney transplant recipient on hemodialysis and concomitant rifampicin therapy]. [PDF]
López-Pay N +8 more
europepmc +1 more source
In vitro antimicrobial activity of Bixa orellana L . Leaves extract against anaerobic bacteria associated to bacterial vaginosis and Lactobacillus spp. [PDF]
Marcas J +4 more
europepmc +1 more source
[Pharmacokinetic interaction between linezolid and rifampicin: A case report]. [PDF]
Fernández-Vázquez A +5 more
europepmc +1 more source
[Achievement of pharmacokinetic/pharmacodynamic targets with linezolid therapeutic drug monitoring in critically ill patients]. [PDF]
Irigoyen Rodriguez I +4 more
europepmc +1 more source

